Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Q&A: AdvaMed Accel's Shadan, Wittorf Outline Lobbying Priorities, More

Executive Summary

In a podcast exclusive with Medtech Insight, the new chair and executive director of small-company-focused AdvaMed Accel discussed their priorities for supporting small medtech companies. Among the topics discussed were the medical device tax, reimbursement uncertainty and empowering women in the industry.

You may also be interested in...

New AdvaMed Board Chair To Make Military Veteran Recruitment A Priority

A former Army ranger, Michael Minogue wants to help military veterans transition into and gain employment opportunities in the medtech industry.

Shadan Brings Multi-Perspective View Of Medtech To AdvaMed Accel Chair Post

Device tax, reimbursement predictability and empowering women in the medtech industry are some of Martha Shadan's top priorities for her two-year term as board chair of AdvaMed Accel, the small-company-advocacy arm of the trade group.

Surgeons Using PODs To Skirt Disclosure, Kickback Rules, Senators Say

Orthopedic and other device-implanting surgeons who participate in physician-owned distributorships are circumventing Stark Law and Sunshine Act requirements to "grant themselves a steady stream of income" by ordering the most expensive implants, and performing some unneeded surgeries, says a Senate Finance Committee report released May 10. It scrutinizes the impact on spine surgeons, in particular.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts